| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | John P Kelly | |
| P2860 | cites work | Khat use and neurobehavioral functions: suggestions for future studies | Q24610235 |
| Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity | Q24631444 | ||
| 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors | Q24645072 | ||
| Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves | Q24679400 | ||
| Khat and alcohol use and risky sex behaviour among in-school and out-of-school youth in Ethiopia | Q24812238 | ||
| Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines | Q28145996 | ||
| Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry | Q28212734 | ||
| Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine | Q28243313 | ||
| Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure | Q28247565 | ||
| Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones | Q28249380 | ||
| Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex | Q28270313 | ||
| Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry | Q28277604 | ||
| A collapse in integrity of scientific advice in the UK | Q28279981 | ||
| Methylone and mCPP, two new drugs of abuse? | Q28284527 | ||
| Effect of Catha edulis foresk (khat) extracts on male rat sexual behavior | Q48425741 | ||
| Behavioral and neurochemical effects of (-)- and (+/-)-cathinone: dose-response and time-course | Q48539061 | ||
| Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats | Q48572473 | ||
| Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo | Q48839869 | ||
| Neurochemical similarities between d,l-cathinone and d-amphetamine | Q48913202 | ||
| Is the forced swimming test a suitable model for revealing antidepressant activity? | Q28290947 | ||
| Methcathinone: a new and potent amphetamine-like agent | Q28300938 | ||
| Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding | Q28378100 | ||
| New designer drug 4′-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography–mass spectrometry | Q30923522 | ||
| Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry | Q31057190 | ||
| Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenone | Q31060075 | ||
| Metabolism and toxicological detection of the new designer drug 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry. | Q31153032 | ||
| Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. | Q33188077 | ||
| Boltushka: a homemade amphetamine-type stimulant and HIV risk in Odessa, Ukraine | Q33659624 | ||
| Khat, driver impairment and road traffic injuries: a view from Ethiopia | Q33689129 | ||
| Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. | Q33738559 | ||
| Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. | Q33955964 | ||
| Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse | Q34004634 | ||
| Manganese and Parkinson's disease: a critical review and new findings | Q34060040 | ||
| Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. | Q34092788 | ||
| Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin | Q34111094 | ||
| An analysis of the 'legal high' mephedrone. | Q34120444 | ||
| Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. | Q34122952 | ||
| Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. | Q34128994 | ||
| Analyses of second-generation 'legal highs' in the UK: initial findings. | Q34129831 | ||
| The naphyrone story: The alpha or beta-naphthyl isomer? | Q34141130 | ||
| Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine | Q34160344 | ||
| In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates | Q34227794 | ||
| Treatment of khat addiction | Q34245490 | ||
| Pharmacodynamics and pharmacokinetics of khat: a controlled study | Q34322352 | ||
| Intravenous self-injection of methcathinone in the baboon | Q34330125 | ||
| Amphetamine-like effects in humans of the khat alkaloid cathinone | Q34357825 | ||
| Combined intoxication with methylone and 5-MeO-MIPT. | Q34552294 | ||
| Two Fatal Intoxications with the New Designer Drug Methedrone (4-Methoxymethcathinone) | Q34625141 | ||
| Illicit cathinone ("Hagigat") poisoning | Q34686684 | ||
| Fluoromethcathinone, a new substance of abuse | Q34938019 | ||
| New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques | Q34951585 | ||
| Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry | Q35012007 | ||
| Intravenous self-administration of (-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane in rhesus monkeys. | Q50575637 | ||
| Relative potencies of two phenylalkylamines found in the abused plant , khat | Q52296566 | ||
| Stimulus properties of antidepressants in the rat. | Q52299559 | ||
| Effect of (-)-cathinone, a psychoactive alkaloid from khat (Catha edulis Forsk.) and caffeine on sexual behaviour in rats. | Q52914128 | ||
| Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. | Q53245448 | ||
| Adverse effects of khat: a review | Q54041871 | ||
| Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types | Q56016847 | ||
| SYNTHETIC HOMOLOGS OF d,l-EPHEDRINE | Q56212536 | ||
| Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition | Q56446476 | ||
| The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs | Q56553418 | ||
| Metabolism of the recently encountered designer drug, methylone, in humans and rats | Q67224666 | ||
| Receptor pharmacology of MDMA and related hallucinogens | Q68163160 | ||
| Determination of (S)-(-)-cathinone and its metabolites (R,S)-(-)-norephedrine and (R,R)-(-)-norpseudoephedrine in urine by high-performance liquid chromatography with photodiode-array detection | Q68226186 | ||
| 'Cat': methcathinone--a new drug of abuse | Q70698408 | ||
| Effect of the alkaloid (-)-cathinone on the release of radioactivity from rat striatal tissue prelabelled with 3H-serotonin | Q70758892 | ||
| Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats | Q70853211 | ||
| Investigation of the impurities found in methamphetamine synthesised from pseudoephedrine by reduction with hydriodic acid and red phosphorus | Q70913312 | ||
| Influence of cathinone (alpha-aminopropiophenone) and cathine (phenylpropanolamine) on circling behavior and on the uptake and release of [3H]dopamine in striatal slices of rats | Q70953108 | ||
| Metabolism of cathinone to d-norpseudoephedrine in humans | Q71107153 | ||
| Detection and identification of pyrovalerone and its hydroxylated metabolite in the rat | Q71813945 | ||
| Possible involvement of amine oxidase inhibition in the sympathetic activation induced by khat (catha edulis) chewing in humans | Q72586388 | ||
| Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function | Q73169490 | ||
| A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants | Q73950418 | ||
| Catha edulis extract and its active principle cathinone induce ipsilateral rotation in unilaterally lesioned rats | Q79189573 | ||
| Über das Vorkommen vond-nor-iso-Ephedrin in Catha edulis | Q104984470 | ||
| Bupropion: pharmacological and clinical profile in smoking cessation. | Q35073939 | ||
| Khat and mushrooms associated with psychosis | Q35719348 | ||
| A review of the neuropharmacological properties of khat. | Q37194030 | ||
| Risk assessment of khat use in the Netherlands: a review based on adverse health effects, prevalence, criminal involvement and public order | Q37265642 | ||
| The stimulant khat--another door in the wall? A call for overcoming the barriers | Q37632876 | ||
| Khat - a controversial plant | Q37634352 | ||
| Khat use and monitoring drug use in Europe: the current situation and issues for the future. | Q37746067 | ||
| Metabolism of designer drugs of abuse: an updated review. | Q37764364 | ||
| A good chew or good riddance--how to move forward in the regulation of khat consumption | Q37775199 | ||
| GHB and synthetic cathinones: clinical effects and potential consequences | Q37940942 | ||
| Khat consumption: a pharmacological review | Q38265856 | ||
| Khat in the Horn of Africa: historical perspectives and current trends | Q38417465 | ||
| Regulating khat--dilemmas and opportunities for the international drug control system | Q38874284 | ||
| The content of psychoactive phenylpropyl and phenylpentenyl khatamines in Catha edulis Forsk. of different origin | Q39190899 | ||
| Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). | Q39193679 | ||
| High relative frequency of oral squamous cell carcinoma in Yemen: qat and tobacco chewing as its aetiological background. | Q39194897 | ||
| Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. | Q39788585 | ||
| Methcathinone is a substrate for the serotonin uptake transporter | Q40615026 | ||
| Methcathinone: a Russian designer amphetamine infiltrates the rural midwest | Q40709467 | ||
| Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone | Q41473516 | ||
| Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. | Q42539187 | ||
| Further research required to determine link between khat consumption and driver impairment | Q42766414 | ||
| The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland | Q42946688 | ||
| A Parkinsonian syndrome in methcathinone users and the role of manganese | Q42977046 | ||
| Leukoencephalopathy associated with khat misuse | Q43072350 | ||
| Purchasing 'legal highs' on the Internet--is there consistency in what you get? | Q43088335 | ||
| UK places generic ban on mephedrone drug family | Q43092499 | ||
| Home secretary bans mephedrone after taking advice from depleted council | Q43113016 | ||
| Cathinone preservation in khat evidence via drying | Q43206975 | ||
| Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure | Q43211659 | ||
| Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry | Q44070377 | ||
| Actions of amphetamine derivatives and cathinone at the noradrenaline transporter | Q44582033 | ||
| MAO inhibition by arylisopropylamines: the effect of oxygen substituents at the beta-position. | Q44972108 | ||
| Quantitative differences in the pharmacological effects of (+)- and (-)-cathinone | Q45079456 | ||
| Methcathione ("cat"): an enantiomeric potency comparison | Q45082071 | ||
| Behavioural sensitisation following repeated intermittent oral administration of Catha edulis in rats | Q45175667 | ||
| (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration | Q45176338 | ||
| Parkinsonism due to ephedrone neurotoxicity: a case report. | Q46005740 | ||
| Modulation of cholinergic contractions of airway smooth muscle by cathinone: potential beneficial effects in airway diseases. | Q46323038 | ||
| Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats | Q46465369 | ||
| Methcathinone: a new postindustrial drug | Q46512505 | ||
| Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats | Q46636501 | ||
| Acute effects of a khat extract on the rat electroencephalogram | Q46862350 | ||
| Kat and its use: an historical perspective | Q47352593 | ||
| P433 | issue | 7-8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 439-453 | |
| P577 | publication date | 2011-07-13 | |
| P1433 | published in | Drug Testing and Analysis | Q3040088 |
| P1476 | title | Cathinone derivatives: a review of their chemistry, pharmacology and toxicology | |
| P478 | volume | 3 |
| Q34464501 | "Word of mouse": indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine |
| Q34115248 | 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry |
| Q41169933 | 3-Methyl-methcathinone: Pharmacokinetic profile evaluation in pigs in relation to pharmacodynamics |
| Q34465568 | A Fatal Case of Pentedrone and α-Pyrrolidinovalerophenone Poisoning |
| Q48625700 | A brief history of 'new psychoactive substances'. |
| Q48505716 | A case of treating cathinone dependence and comorbid depression using bupropion |
| Q38120432 | Abuse liability of novel 'legal high' designer stimulants: evidence from animal models |
| Q47585671 | An Internet Study of User's Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC). |
| Q83354105 | Annual banned-substance review: analytical approaches in human sports drug testing |
| Q38333687 | Bath Salt-Induced Psychosis: Nursing Assessment, Diagnosis, Treatment, and Outcomes |
| Q36709254 | Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. |
| Q35754464 | Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention |
| Q35737691 | Before the ban--an exploratory study of a local khat market in East London, U.K. |
| Q53824147 | Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat. |
| Q53192559 | Cathinones: Isotopic profiling as an aid to linking seizures. |
| Q38402139 | Comorbid psychopathology and everyday functioning in a brief intervention study to reduce khat use among Somalis living in Kenya: description of baseline multimorbidity, its effects of intervention and its moderation effects on substance use. |
| Q41544518 | Comparison of 3 Derivatization Methods for the Analysis of Amphetamine-Related Drugs in Oral Fluid by Gas Chromatography-Mass Spectrometry |
| Q53687526 | DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants. |
| Q30300017 | Designer drugs 2015: assessment and management |
| Q89017240 | Determination of a threshold fatal 3-MMC concentration in human: mission impossible |
| Q44883616 | Distinguishing two isomeric mephedrone substitutes with selective reagent ionisation mass spectrometry (SRI-MS). |
| Q36634004 | E-Cigarette as a Harm Reduction Approach among Tobacco Smoking Khat Chewers: A Promising Bullet of Multiple Gains |
| Q39714625 | Editor's Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines). |
| Q37663461 | Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals |
| Q37381303 | Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus |
| Q47110356 | Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study |
| Q62659650 | Enantiomeric separation of new cathinone derivatives designer drugs by capillary electrochromatography using a chiral stationary phase, based on amylosetris(5-chloro-2-methylphenylcarbamate) |
| Q48380075 | Fatal Intoxication with α-PVP, a Synthetic Cathinone Derivative |
| Q39761680 | First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry |
| Q46475968 | Formation of odd-electron product ions in collision-induced fragmentation of electrospray-generated protonated cathinone derivatives: aryl α-primary amino ketones |
| Q47680222 | Identification of three new phase II metabolites of a designer drug methylone formed in rats by N-demethylation followed by conjugation with dicarboxylic acids. |
| Q28255977 | Impact of the emergence of designer drugs upon sports doping testing |
| Q34273882 | In vitro metabolism studies on mephedrone and analysis of forensic cases |
| Q34504512 | In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant |
| Q39324097 | Khat Use: What Is the Problem and What Can Be Done? |
| Q38169542 | Khat and synthetic cathinones: a review |
| Q36074135 | Late presentation for diagnosis of HIV infection among HIV positive patients in South Tigray Zone, Ethiopia |
| Q47414672 | Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users. |
| Q36703786 | Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA |
| Q28483841 | Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion |
| Q24621938 | Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum |
| Q38038819 | Natural product 'legal highs'. |
| Q26752739 | Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants |
| Q38983638 | Neurotoxicology of Synthetic Cathinone Analogs |
| Q41462770 | Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs |
| Q103827134 | Optimization and validation of a new approach based on CE-HRMS for the screening analysis of Novel Psychoactive Substances (cathinones, phenethylamines, tryptamines) in urine |
| Q88842428 | Organic impurity profiling of methylone and intermediate compounds synthesized from catechol |
| Q28273207 | Pharmacological characterization of designer cathinones in vitro |
| Q36851442 | Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs |
| Q34122902 | Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). |
| Q37161370 | Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters. |
| Q38064910 | Poisoning with illicit substances: toxicology for the anaesthetist |
| Q37672302 | Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death |
| Q28270808 | Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV) |
| Q34270004 | Prevalence of new psychoactive substances: A retrospective study in hair |
| Q95854597 | Psychoactive Bath Salts and Neurotoxicity Risk |
| Q53088893 | Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones. |
| Q29395533 | Recent advances in forensic drug analysis by DART-MS |
| Q34204779 | Severity of khat dependence among adult khat chewers: the moderating influence of gender and age. |
| Q45219952 | Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry |
| Q50102199 | Structure determination of butylone as a new psychoactive substance using chiroptical and vibrational spectroscopies. |
| Q50300878 | Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release |
| Q54562572 | Study of collision-induced dissociation of electrospray-generated protonated cathinones. |
| Q28288908 | Substituted methcathinones differ in transporter and receptor interactions |
| Q37146920 | Successful quantification of 4'-methyl-α-pyrrolidinohexanophenone (MPHP) in human urine using LC-TOF-MS in an autopsy case |
| Q36996570 | Synthetic cathinone abuse |
| Q34443994 | The analysis of amphetamine-like cathinone derivatives using positive electrospray ionization with in-source collision-induced dissociation |
| Q41256935 | The physiological and perceptual effects of plant extracts (Catha Edulis Forsk) during sustained exercise. |
| Q30412911 | The preclinical pharmacology of mephedrone; not just MDMA by another name. |
| Q38100197 | The role of dopamine receptors in the neurotoxicity of methamphetamine. |
| Q45034079 | Twenty-One Cases Involving Alpha-Pyrrolidinovalerophenone (α-PVP). |
| Q39010900 | When "Chems" Meet Sex: A Rising Phenomenon Called "ChemSex". |
| Q59218491 | α-PVP (“flakka”): a new synthetic cathinone invades the drug arena |
Search more.